RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
18 sept. 2023 05h59 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a video webinar regarding...
RetinalGenix Technologies Inc. Announces the Addition of Fred Chasalow, Ph.D., to the Medical Advisory Board of DNA-GPS
28 août 2023 06h35 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) today announced the addition of Fred Chasalow, Ph.D., to the...
RetinalGeniX Technologies Inc. Granted Patent for Patient Home Monitoring and Physician Alert System for Ocular Anatomy
28 juil. 2023 13h24 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 28, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), this week was granted a patent for its Patient Home Monitoring...
Global Color Blind Glasses Markets, 2023-2030: Innovative 3D Printing Technology and Government Initiatives Propel Adoption
26 juil. 2023 04h43 HE
|
Research and Markets
Dublin, July 26, 2023 (GLOBE NEWSWIRE) -- The "Global Color Blind Glasses Markets, 2023-2030" report has been added to ResearchAndMarkets.com's offering. Global Color Blind Glasses Market to...
Diabetic Retinopathy Global Market to 2030: Increasing Prevalence of Blindness due to Diabetes Drives Growth
29 juin 2023 07h03 HE
|
Research and Markets
Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative DR, Non-proliferative DR), By Management (Intraocular...
RetinalGeniX Technologies, Inc. Nears Completion of Institutional Review Board for Research on DNA/GPS Program
26 juin 2023 06h15 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), today previewed the completion of an Institutional Review Board...
Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
12 juin 2023 02h00 HE
|
Beacon Therapeutics
PRESS RELEASE Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness New leading gene therapy company...
Retinalgenix Technologies, Inc. Expands Team to Hasten the Launch of DNA/GPS
07 juin 2023 05h35 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the hiring of Owen Watson, MS. Mr. Watson’s...
Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol (ALK-001) in the Treatment of Stargardt Disease
05 juin 2023 06h00 HE
|
Alkeus Pharmaceuticals
CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals announced today that it has raised a $150 million Series B financing to support the registration and launch of...
Fundus Camera Global Market Report 2023: Increasing Number of Product Launches by Key Players is Expected to Propel Growth
01 mars 2023 09h48 HE
|
Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Fundus Camera Market, by Product Type, by Modality, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report...